beta
TXAC
Therapeutics Acquisition Corp.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Therapeutics Acquisition Corp. is a blank check company with a purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Peter Kolchinsky and Matthew Hammond on April 15, 2020 and is headquartered in Boston, MA.
Market Cap: 197 Million
Primary Exchange: NASDAQ
Shares Outstanding: 15.2 Million
Float:
Dividend: (%)
Beta: 1.4125439484366917
Sector: Finance
Industry: Financial Conglomerates
Ethical Flags
Longest drawdown: 19 trading days
From: 2020-07-10 To: 2020-08-06
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|